MSB 2.58% 94.5¢ mesoblast limited

Alzheimer drug approved, page-24

  1. 5,784 Posts.
    lightbulb Created with Sketch. 2103
    Really good article about this really crazy situation in buzzfeed


    https://www.buzzfeednews.com/article/stephaniemlee/alzheimers-aducanumab-biogen-fda-approval?origin=web-hf

    A Highly Controversial Alzheimer’s Treatment Won FDA Approval. Scientists Say We Don’t Know If It Actually Works.

    In one sense, aducanumab is a historic drug — but many scientists say its approval is a triumph of business interests over public health.

    Last updated on June 7, 2021, at 7:45 p.m. ET

    Posted on June 7, 2021, at 1:20 p.m. ET






 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.